| Financial Year |
March 31 2023 |
| Monetary Funds |
8,105,205.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
6,750,938.06 |
| Advances to Suppliers |
3,404,232.19 |
| Other Receivables |
43,210,603.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
336,862.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,441,857.32 |
| Total Current Assets |
64,249,698.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,860,441.77 |
| Investment Properties |
46,018,655.48 |
| Fixed Assetes |
16,938,876.03 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,625.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
31,094.79 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
137,570,187.93 |
| Total Assets |
201,819,886.70 |
| Short-Term Loans |
980,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,623,698.41 |
| Accounts Received In Advance |
1,396,172.10 |
| Employee Compensation Payable |
2,709,065.44 |
| Taxes Payable |
265,760.90 |
| Interest Payable |
460,877.02 |
| Dividend Payable |
-- |
| Other payables |
33,782,866.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
73,548,900.32 |
| Other Current Liabilities |
338,778.53 |
| Sub-Total of Current Liabilities |
120,952,074.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
263,051.41 |
| Total Liabilities |
121,215,126.12 |
| Paid-In Capital(Or Share Stock) |
765,799,353.00 |
| Capital Surplus |
2,117,647,291.15 |
| Surplus Reserve |
28,016,004.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,851,322,297.75 |
| Minority Stockholder's Interest |
30,511,409.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
50,093,350.93 |
| Owner's Equity（Stockholder's Equity） |
80,604,760.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
201,819,886.70 |
